Thursday - March 5, 2026
Research Spotlight: Exploring Combination Therapy to Improve Outcomes in NF2-Related Schwannomatosis
February 13, 2026
BOSTON, Massachusetts, Feb. 13 [Category: BizHospital] -- Mass General Brigham issued the following news release:

* * *

Research Spotlight: Exploring Combination Therapy to Improve Outcomes in NF2-Related Schwannomatosis

*

Lei Xu, MD, PhD, of the Steele Laboratories within the Mass General Brigham Cancer Institute, is the senior author of a paper published in Nature Communications, " NKG2D Upregulation Sensitizes Tumors to Combined Anti-PD . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products